Clinical Trial Update: Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) [Phase 3]

View source ↗

Summary

A Phase 3 parallel-arm trial evaluating AD109 versus placebo in obstructive sleep apnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• AD109

Snippet

Sponsor: Apnimed | Conditions: OSA | Phase 3 | Status: COMPLETED